Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback